<DOC>
<DOCNO>
EP-0013263
</DOCNO>
<TEXT>
<DATE>
19800709
</DATE>
<IPC-CLASSIFICATIONS>
A61K-9/22 A61K-9/56 B02C-1/00 <main>A61K-9/24</main> A61K-9/52 A61K-9/16 B02C-19/00 A61K-9/32 A61M-5/32 
</IPC-CLASSIFICATIONS>
<TITLE>
a pharmaceutical preparation comprising a cardiac glycoside in combination with a polymer, and a process for preparation thereof.
</TITLE>
<APPLICANT>
haessle abse<sep>aktiebolaget hassle<sep>aktiebolaget hässlekärragatan 5s-431 83 mölndalse<sep>aktiebolaget hassle  <sep>
</APPLICANT>
<INVENTOR>
appelgren curt henry<sep>bogentoft conny borje<sep>appelgren, curt henry<sep>bogentoft, conny borje<sep>appelgren, curt henrykronoparksvägen 6s-434 00 kungsbackase<sep>bogentoft, conny börjebäckvägen 12s-430 50 kalleredse<sep>appelgren, curt henry<sep>bogentoft, conny borje<sep>appelgren, curt henrykronoparksvägen 6s-434 00 kungsbackase<sep>bogentoft, conny börjebäckvägen 12s-430 50 kalleredse<sep>
</INVENTOR>
<ABSTRACT>
a solid pharmaceutical preparation for administration in  dosage unit form comprising a therapeutically effective car­ diac glycoside, whereby each dosage unit is to comprise a  plurality of bodies, each of said bodies having a pharmaceuti­ cally inert core and a layer thereon containing the glycoside  and a polymer insoluble in gastric juice and soluble in intesti­ nal juice, a process for preparing such preparation and a  method of treatment employing the same.  
</ABSTRACT>
</TEXT>
</DOC>
